NCT02095249View on ClinicalTrials.gov

Prostate Hypoxia - TIC

NAActive, not recruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Prostate Cancer
Interventions
DRUG

Pimonidazole

Pimonidazole is to be administered to patients scheduled for radical prostatectomy one day prior to surgery.

Trial Locations (1)

M5G2M9

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02095249 - Prostate Hypoxia - TIC | Biotech Hunter | Biotech Hunter